BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9491282)

  • 1. Tacrolimus rescue therapy in patients with rejection and long-term dialysis after kidney transplantation.
    Witzke O; Becker G; Erhard J; Lütkes P; Szabo A; Philipp T; Heemann U
    Clin Nephrol; 1998 Jan; 49(1):24-7. PubMed ID: 9491282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T
    Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus rescue therapy for children with acute renal transplant rejection.
    Hymes LC; Warshaw BL
    Pediatr Nephrol; 2001 Dec; 16(12):990-2. PubMed ID: 11793086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation.
    Pascher A; Radke C; Dignass A; Schulz RJ; Veltzke-Schlieker W; Adler A; Sauer IM; Platz K; Klupp J; Volk HD; Neuhaus P; Mueller AR
    Transplantation; 2003 Aug; 76(3):615-8. PubMed ID: 12923454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is tacrolimus effective for ongoing renal allograft rejection?].
    Nishioka T; Imanishi M; Akiyama T; Kurita T; Kokado Y; Takahara S; Ito K; Sagawa S; Higashi Y; Otomo Y; Hayashi T
    Hinyokika Kiyo; 1998 May; 44(5):369-72. PubMed ID: 9656112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
    Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR
    Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
    Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
    Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
    Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
    Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients.
    Chang RW; Snowden S; Palmer A; Kwan JT; Nicholson M; Kashi SH; Fernando ON; Perner F; Neild GH
    Transpl Int; 2001 Dec; 14(6):384-90. PubMed ID: 11793035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.